Loading company…
UK diagnostics company developing rapid point-of-care tests for infection and inflammation, including TRISEP.
Septest Limited is a biotechnology and medical diagnostics company developing rapid point-of-care tests for early detection of infections and inflammatory conditions, led by its TRISEP test. Its work covers sepsis, antimicrobial resistance, pneumonia, tuberculosis and autoimmune diseases. Founded in 2022 by CTO Alistair Wilson and based in Hertford, UK, it raised USD 550,000 in pre-seed funding in March 2026, led by Kappika, with participation from Oxford Innovation Finance. As of October 2026, Jag Grewal is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in